Cite
Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study.
MLA
Al Sulaiman, Khalid, et al. “Ascorbic Acid as an Adjunctive Therapy in Critically Ill Patients with COVID-19: A Propensity Score Matched Study.” Scientific Reports, vol. 11, no. 1, Sept. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1038/s41598-021-96703-y.
APA
Al Sulaiman, K., Aljuhani, O., Saleh, K. B., Badreldin, H. A., Al Harthi, A., Alenazi, M., Alharbi, A., Algarni, R., Al Harbi, S., Alhammad, A. M., Vishwakarma, R., & Aldekhyl, S. (2021). Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Scientific Reports, 11(1), 1–8. https://doi.org/10.1038/s41598-021-96703-y
Chicago
Al Sulaiman, Khalid, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, et al. 2021. “Ascorbic Acid as an Adjunctive Therapy in Critically Ill Patients with COVID-19: A Propensity Score Matched Study.” Scientific Reports 11 (1): 1–8. doi:10.1038/s41598-021-96703-y.